| Hang Seng Index | 25.360 HKD | +0.160 | +0.635% | 499.09M | 12.62B | 25.231 (+0.512%) HKD as at 2025/08/04 | | |
| Hang Seng China Enterprises | 91.440 HKD | +0.460 | +0.506% | 48.45M | 4.42B | 91.032 (+0.448%) HKD as at 2025/08/04 | | |
| Hang Seng TECH Index | 5.415 HKD | +0.045 | +0.838% | 781.76M | 4.23B | 5.386 (+0.544%) HKD as at 2025/08/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 5.450 HKD | +0.060 | +1.113% | 130.83M | 711.53M | 5.419 (+0.566%) HKD as at 2025/08/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.578 HKD | -0.018 | -1.128% | 177.02M | 279.97M | 1.590 (-0.748%) HKD as at 2025/08/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.054 HKD | -0.024 | -1.155% | 83.84M | 173.04M | 2.076 (-1.036%) HKD as at 2025/08/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.615 HKD | +0.060 | +1.080% | 26.11M | 145.79M | 5.561 (+0.973%) HKD as at 2025/08/04 | | |
| Hang Seng TECH Index | 11.610 HKD | +0.080 | +0.694% | 12.14M | 140.77M | 11.375 (+2.067%) HKD as at 2025/08/01 | | |
| Hang Seng TECH Index | 5.500 HKD | +0.040 | +0.733% | 16.87M | 92.59M | 5.469 (+0.574%) HKD as at 2025/08/04 | | |
| Hang Seng China Enterprises | 10.570 HKD | +0.030 | +0.285% | 8.36M | 88.29M | 10.418 (+1.457%) HKD as at 2025/08/01 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 16.980 HKD | +0.670 | +4.108% | 4.96M | 83.21M | 16.374 (+3.698%) HKD as at 2025/08/04 | | |
| FTSE China A50 | 13.800 HKD | +0.050 | +0.364% | 2.48M | 34.17M | 13.711 (+0.652%) HKD as at 2025/08/04 | | |
| FTSE US Treasury 20+ Years Index | 68.940 HKD | +0.540 | +0.789% | 467.61K | 32.27M | 68.854 (+0.125%) HKD as at 2025/08/01 | | |
| FTSE China A50 | 14.820 HKD | +0.140 | +0.954% | 2.10M | 31.08M | 14.610 (+1.439%) HKD as at 2025/08/01 | | |
| London Gold Fixing Price | 2,439.000 HKD | +11.000 | +0.453% | 11.22K | 27.37M | N/A | | |
| CSI 300 | 46.300 HKD | +0.380 | +0.828% | 551.51K | 25.50M | 46.030 (+0.587%) HKD as at 2025/08/04 | | |
| HSI ESG Enhanced Index (net total return index) | 52.860 HKD | +0.460 | +0.878% | 410.48K | 21.70M | 52.335 (+1.004%) HKD as at 2025/08/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 3.858 HKD | -0.118 | -2.968% | 5.00M | 19.27M | 4.019 (-4.011%) HKD as at 2025/08/01 | | |
| Hang Seng High Dividend Yield | 29.860 HKD | +0.360 | +1.220% | 545.23K | 16.20M | 29.378 (+1.639%) HKD as at 2025/08/01 | | |
| MSCI China | 25.760 HKD | +0.260 | +1.020% | 608.86K | 15.61M | 25.279 (+1.902%) HKD as at 2025/08/01 | | |
| Hang Seng Index | 23.220 CNY | +0.160 | +0.694% | 541.01K | 12.54M | 23.076 (+0.626%) CNY as at 2025/08/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 37.600 HKD | +1.220 | +3.353% | 294.30K | 11.04M | 36.114 (+4.114%) HKD as at 2025/08/01 | | |
| CME CF Bitcoin Reference Rate- Asia Pacific Variant | 14.160 HKD | -0.030 | -0.211% | 743.20K | 10.53M | 14.168 (-0.054%) HKD as at 2025/08/04 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.230 HKD | +0.210 | +1.234% | 588.60K | 10.14M | 16.941 (+1.706%) HKD as at 2025/08/01 | | |
| CME CF Ether-Dollar Reference Rate - Asia Pacific Variant | 8.740 HKD | +0.225 | +2.642% | 1.07M | 9.38M | 8.509 (+2.710%) HKD as at 2025/08/04 | | |
| CSI 300 | 42.400 CNY | +0.400 | +0.952% | 153.80K | 6.49M | 42.103 (+0.705%) CNY as at 2025/08/04 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.590 HKD | -0.017 | -2.801% | 9.57M | 5.64M | 0.615 (-4.003%) HKD as at 2025/08/01 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.924 HKD | +0.056 | +1.448% | 1.40M | 5.49M | 3.908 (+0.420%) HKD as at 2025/08/04 | | |
| SSE Science and Technology Innovation Board 50 Index | 9.675 HKD | +0.005 | +0.052% | 545.90K | 5.26M | 9.711 (-0.374%) HKD as at 2025/08/04 | | |
| CSI China Reform Hong Kong Connect Central-SOEs High Dividend Yield Index | 9.925 HKD | +0.055 | +0.557% | 507.41K | 5.02M | 9.781 (+1.475%) HKD as at 2025/08/04 | | |